AKR1B10 and hepatocellular carcinoma: Two similar studies have demonstrated that patients with chronic hepatitis B (Li et al., 2008) and chronic hepatitis C (Murata et al., 2016) expressed high levels of AKR1B10 and its expression acted as an independent risk factor for HCC development.